跳至主要内容
临床试验/NCT04128202
NCT04128202已完成不适用

Online Intervention to Prevent Perinatal Depression and Promote Breastfeeding

University of Illinois at Chicago2 个研究点 分布在 1 个国家目标入组 22 人开始时间: 2020年6月15日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
22
试验地点
2
主要终点
Patient Health Questionnaire-9 (PHQ-9)

研究概览

简要总结

"SunnysidePlus" will functionally integrate a web based intervention targeting skills to promote and support breastfeeding, manage mood,and prevent depression. Sunnyside Plus will build upon the previously tested "Sunnyside" intervention which targeted skills to manage mood through an interactive website with didactic material and tools. Women in weeks 20-28 of their pregnancy will be randomized to receive either Sunnyside Plus or Sunnyside. The Sunnyside intervention will consist of 6 weeks of online lessons during pregnancy and booster sessions at 2 weeks, 4 weeks, and 6 weeks postpartum. Sunnyside Plus will include additional education and support to improve breastfeeding outcomes. Breastfeeding education and skills will be provided during the 6 weeks of online lessons during pregnancy. Breastfeeding support will continue through 6 weeks postpartum. This postpartum support will involve weekly online lessons, text support, and video support calls with a Lactation Educator provided on an as-needed basis. SunnysidePlus has the potential to provide a novel paradigm for improving breastfeeding outcomes and preventing depression; one that is accessible, highly scalable and cost-effective.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Black or African American
  • 18 years and older
  • Pregnant and between 20 and 28 weeks gestation
  • Intend to breastfeed their child
  • Have a score of 5-14 on the Patient Health Questionnaire-8 (PHQ-8)
  • Have access to a broadband internet connection
  • Are able to read and speak English

排除标准

  • Are pregnant with multiples
  • Have visual, hearing, voice, or motor impairment that would prevent completion of study procedures
  • Diagnosed with a major depressive episode, psychotic disorder, bipolar disorder, dissociative disorder, substance use disorder or other diagnosis for which participation in this trial is either inappropriate or dangerous based on self-report
  • Are currently receiving treatment (medication or psychotherapy),have an intention to resume antidepressant medication after delivery (i.e., women who discontinued their medication during pregnancy).

结局指标

主要结局

Patient Health Questionnaire-9 (PHQ-9)

时间窗: 2 weeks

The PHQ-9 is composed of 9 scored items and 1 unscored item which reflect overall functioning and impairment due to the depressive symptoms. PHQ-9 scoring interpretations are as follows: 1-4: minimal depressive symptoms; 5-9 mild depressive symptoms; 10-14: moderate depressive symptoms; 15-19: moderately severe depressive symptoms: 20-27: severe depressive symptoms.

Breastfeeding Status

时间窗: Through 12 weeks postpartum

Breastfeeding initiation, exclusivity, and duration will be assessed in the postpartum period.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Jennifer Duffecy

Principal Investigator

University of Illinois at Chicago

研究点 (2)

Loading locations...

相似试验